REGEN BIOPHARMA, INC.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Jun 2017 | — | -502.8% | -2,384.9% |
| Jun 2018 | — | -125.2% | -107.6% |
| Dec 2018 | — | -725.0% | 893.6% |
| Mar 2019 | — | -841.5% | -1,214.9% |
| Jun 2019 | — | -502.2% | -16,062.3% |
| Sep 2019 | — | -683.3% | 6,744.9% |
| Dec 2019 | — | -491.3% | 11,240.7% |
| Mar 2020 | — | -143.4% | -14,866.5% |
| Jun 2020 | — | -59.6% | 11,689.9% |
| Sep 2020 | — | -68.2% | 4,338.5% |
| Dec 2020 | — | -67.4% | 6,076.1% |
| Mar 2021 | — | -47.3% | 1,612.3% |
| Jun 2021 | — | -145.5% | -25,642.4% |
| Sep 2021 | — | 554.8% | 6,056.6% |
| Dec 2021 | — | -336.4% | 8,359.6% |
| Mar 2022 | — | -247.2% | -216,776.8% |
| Jun 2022 | — | -188.3% | 213,978.5% |
| Sep 2022 | — | -309.0% | -246.6% |
| Dec 2022 | — | -1,466.1% | 5,169.8% |
| Mar 2023 | — | -249.2% | -173.8% |
| Jun 2023 | — | -144.2% | -168.0% |
| Sep 2023 | — | -1,401.8% | -7,711.2% |
| Dec 2023 | — | -388.1% | -458.1% |
| Mar 2024 | — | -319.4% | -387.0% |
| Jun 2024 | — | -182.8% | -220.3% |
| Sep 2024 | — | -74.8% | -237.1% |
| Dec 2024 | — | -103.9% | -872.6% |
| Mar 2025 | — | -191.9% | -32.8% |
| Jun 2025 | — | -69.0% | -283.2% |
| Sep 2025 | — | -207.3% | -964.3% |
| Dec 2025 | — | -933.9% | -1,638.6% |
| Mar 2026 | — | -260.2% | 1,679.4% |
| Jun 2026 | — | 41.5% | -1,079.8% |